These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36811536)

  • 1. BIOMAGNETISM OF DRUG-SENSITIVE AND DRUG-RESISTANT MALIGNANT TUMORS AFTER INJECTION OF FERROMAGNETIC NANOCOMPOSITE.
    Todor IN; Lukianova NY; Primin MA; Nedayvoda IV; Chekhun VF
    Exp Oncol; 2022 Dec; 44(4):320-323. PubMed ID: 36811536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomagnetism of tumor in rats with Guerin's carcinoma after injection of ferromagnetic nanocomposite (Ferroplat): contactless measurement.
    Todor IN; Lukianova NY; Primin MА; Nedayvoda IV; Chekhun VF
    Exp Oncol; 2020 Sep; 42(3):204-207. PubMed ID: 32996742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of plant biocomposites based on Georgian tea "per se" and in combination with cisplatin on Walker carcinosarcoma W-256 and Guerin's carcinoma growth rate in rats].
    Zalietok SP; Orlovs'kyĭ OA; Hohol' SV; Samoĭlenko OA; Hulua L; Kvesitadze HI
    Lik Sprava; 2006 Dec; (8):89-93. PubMed ID: 17427433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of biochemical and morphological parameters in rats with Walker 256 and Walker 256/DOX carcinosarcoma.
    Yushko LA; Sarnatskaya VV; Sakhno LA; Hudenko NV; Paziuk LM; Maslenny VN; Melnyk VO; Nikolaev VG
    Exp Oncol; 2021 Mar; 43(1):21-25. PubMed ID: 33785723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells.
    Boroday NV; Chekhun VF
    Exp Oncol; 2018 Mar; 40(1):42-47. PubMed ID: 29600974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of tumor drug resistance phenotype on the dynamics of cisplatin-induced changes of rat peripheral lymphocyte chromatin structure in Guerin's carcinoma].
    Chekhun VF; Ganina KP; Kulik GI; Solianik GI; Kunskaia LN; Gushchenko NN
    Tsitol Genet; 2000; 34(5):11-7. PubMed ID: 11213624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural changes of serum albumin in response to oxidative stress caused by Walker-256 carcinosarcoma growth.
    Sarnatskaya VV; Yushko LA; Prokopenko IV; Hudenko NV; Maslenny VN; Paziuk LM; Bubnovskaya LN; Nikolaev VG
    Exp Oncol; 2020 Mar; 42(1):40-45. PubMed ID: 32231185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional pH-sensitive superparamagnetic iron-oxide nanocomposites for targeted drug delivery and MR imaging.
    Zhu L; Wang D; Wei X; Zhu X; Li J; Tu C; Su Y; Wu J; Zhu B; Yan D
    J Control Release; 2013 Aug; 169(3):228-38. PubMed ID: 23485450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of ferromagnetic nanocomposite (Ferroplat) on human breast cancer cells of different malignancy degrees: pro/antioxidant balance and energy metabolism.
    Chekhun VF; Todor IN; Lukianova NY; Horbyk DM; Lozovskaya YV; Burlaka AP; Borikun TV
    Exp Oncol; 2018 Dec; 40(4):268-274. PubMed ID: 30593756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution characteristics of carboxymethylpullulan-peptide-doxorubicin conjugates in tumor-bearing rats: different sequence of peptide spacers and doxorubicin contents.
    Nogusa H; Yamamoto K; Yano T; Kajiki M; Hamana H; Okuno S
    Biol Pharm Bull; 2000 May; 23(5):621-6. PubMed ID: 10823676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total proteolytic activity and content of the main proteinase inhibitors in blood plasma of rats bearing doxorubicin-sensitive and doxorubicin-resistant Guerin carcinoma.
    Chekhun VF; Kovtonyuk OV; Todor IN; Kulik GI; Tryndiak VP
    Exp Oncol; 2004 Sep; 26(3):232-5. PubMed ID: 15494693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of cisplatin and doxorubicin by carboxylic acid functionalized poly (hydroxyethyl methacrylate)/reduced graphene nanocomposite for combination chemotherapy of breast cancer cells.
    Astani S; Salehi R; Massoumi B; Massoudi A
    J Biomater Sci Polym Ed; 2021 Apr; 32(5):657-677. PubMed ID: 33347395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of different immunotherapy approaches toward treatment of doxorubicin-resistant and doxorubicin-sensitive transplantable rhabdomyosarcoma.
    Belova OB; Vinnichuk UD; Shlakhovenko VA; Berezhnaya NM
    Exp Oncol; 2007 Dec; 29(4):272-6. PubMed ID: 18199982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization.
    Tinkov S; Coester C; Serba S; Geis NA; Katus HA; Winter G; Bekeredjian R
    J Control Release; 2010 Dec; 148(3):368-72. PubMed ID: 20868711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects induced by a 50 Hz electromagnetic field and doxorubicin on Walker-256 carcinosarcoma growth and hepatic redox state in rats.
    Orel VE; Krotevych M; Dasyukevich O; Rykhalskyi O; Syvak L; Tsvir H; Tsvir D; Garmanchuk L; Orel VВ; Sheina I; Rybka V; Shults NV; Suzuki YJ; Gychka SG
    Electromagn Biol Med; 2021 Oct; 40(4):475-487. PubMed ID: 34392747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs.
    Yalovenko TM; Todor IM; Lukianova NY; Chekhun VF
    Exp Oncol; 2016 Jun; 38(2):84-8. PubMed ID: 27356575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green tea, red wine and lemon extracts reduce experimental tumor growth and cancer drug toxicity.
    Zaletok SP; Gulua L; Wicker L; Shlyakhovenko VA; Gogol S; Orlovsky O; Karnaushenko OV; Verbinenko A; Milinevska V; Samoylenko O; Todor I; Turmanidze T
    Exp Oncol; 2015 Dec; 37(4):262-71. PubMed ID: 26710838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
    Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
    J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local application of doxorubicin- loaded Iron oxid nanoparticles and the vascular disrupting agent via the hepatic artery: chemoembolization-photothermal ablation treatment of hepatocellular carcinoma in rats.
    Yuan H; Li X; Tang J; Zhou M; Liu F
    Cancer Imaging; 2019 Nov; 19(1):71. PubMed ID: 31685015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats.
    Petrovic D; Seke M; Borovic ML; Jovic D; Borisev I; Srdjenovic B; Rakocevic Z; Pavlovic V; Djordjevic A
    Exp Mol Pathol; 2018 Jun; 104(3):199-211. PubMed ID: 29727604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.